These findings suggested the presence of a dysregulated molecular network involving SOCS3, miR-124-3p, and B4GALT1, which may provide novel insights into tumor biology and present a useful target for therapeutic interference of CML under certain circumstances. Here, B4GALT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.